Page last updated: 2024-09-02

bn 50739 and thromboxanes

bn 50739 has been researched along with thromboxanes in 1 studies

Compound Research Comparison

Studies (bn 50739)	Trials (bn 50739)	Recent Studies (post-2010) (bn 50739)	Studies (thromboxanes)	Trials (thromboxanes)	Recent Studies (post-2010) (thromboxanes)
57	0	1	3,202	149	199

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Esser, KM; Farhat, M; Feuerstein, G; Rabinovici, R; Slivjak, M; Smith, EF; Yue, TL	1

Other Studies

1 other study(ies) available for bn 50739 and thromboxanes

Article	Year
Platelet activating factor (PAF) and tumor necrosis factor-alpha (TNF alpha) interactions in endotoxemic shock: studies with BN 50739, a novel PAF antagonist. The Journal of pharmacology and experimental therapeutics, 1990, Volume: 255, Issue:1 Topics: Animals; Azepines; Blood Cells; Hemodynamics; Humans; Lipopolysaccharides; Male; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Rats, Inbred Strains; Recombinant Proteins; Shock, Septic; Thromboxanes; Triazoles; Tumor Necrosis Factor-alpha	1990

Article

Year

Platelet activating factor (PAF) and tumor necrosis factor-alpha (TNF alpha) interactions in endotoxemic shock: studies with BN 50739, a novel PAF antagonist.

The Journal of pharmacology and experimental therapeutics, 1990, Volume: 255, Issue:1

Topics: Animals; Azepines; Blood Cells; Hemodynamics; Humans; Lipopolysaccharides; Male; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Rats, Inbred Strains; Recombinant Proteins; Shock, Septic; Thromboxanes; Triazoles; Tumor Necrosis Factor-alpha

1990